Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acacia Research Corporation
CombiMatrix launches siRNA for drug discovery research
September 10th, 2003
Acacia Research Corporation (CBMX, ACTG) announced that CombiMatrix has launched siRNA Solutions, which partners its RNAi synthesis platform and custom microarray technology with sophisticated bioinformatics to provide collaborators and customers with a fully integrated program for drug discovery. The CombiMatrix program is the first to provide a fully integrated service based on a single research platform for discovery. RNAi technologies are predicted to speed discovery of drug development and significantly reduce costs for biotech and pharmaceutical companies. Collaborators will have access to CombiMatrix's complete integrated solution for siRNA...
Source: Biotech Week (2003-09-10)
|
